Petroselinum crispum extract attenuates hepatic steatosis in rats fed with fructose enriched diet

Bratislava Medical Journal

Volumn 116, Issue 9, 2015, Pages 547-553

  Yuneesha Nair, V ^a,b   Balakrishanan, N ^b   Victor Antony Santiago, J ^b  

^a LA TROBE UNIVERSITY   (Australia)

^b ASIA Metropolitan University   (Malaysia)

Author keywords

Lipid hepatic function indicator; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Petroselinum crispum

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; FRUCTOSE; PLANT EXTRACT; SWEETENING AGENT;

ANIMAL; CHEMICALLY INDUCED; DIET; DRUG EFFECTS; FATTY LIVER; LIVER; LIVER FUNCTION TEST; MALE; METABOLISM; PATHOLOGY; PETROSELINUM; PHYTOTHERAPY; RAT;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DIET; FATTY LIVER; FRUCTOSE; LIVER; LIVER FUNCTION TESTS; MALE; PETROSELINUM; PHYTOTHERAPY; PLANT EXTRACTS; RATS; SWEETENING AGENTS;

EID: 84953393906     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2015_107     Document Type: Article

References (43)

1. McCullough AJ. The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 2004; 8: 521-533.
2. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-2474.
3. Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560-578.
4. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17: S186-S190.
5. Fabbrini E, Sullivan S, Klein S. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010; 51: 679-689.
6. Abdelmalek MF, Diehl AM. Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am 2007; 91: 1125-1149.
7. World Gastroenterology Organisation (WGO) Global Guidelines, LaBrecque D, Abbas Z, Anania F, Ferenci P, Khan AG, Goh KL, Hamid SS, Isakov V, Lizarzabal M, Pernaranda MM, Rivera Ramos JF, Sarin S, Štimac D, Thomson ABR, Umar M, LeMair A, Krabshuis J. Meta-analyses, Systematic reviews, Practice guidelines: 27 Abstracts. Non alcoholic Fatty Liver Disease and Non alcoholic Steatohepatitis 2012; 1-29.
8. Basaranoglu M, Basaranoglu G, Sabuncu T, Sentürk H. Fructose as a key player in the development of fatty liver disease. World J Gastroenterol 2013;19:1166-1172.
9. Vos MB, Lavine JE. Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013; 57: 2525-2531.
10. Pollock NK, Bundy V, Kanto W, Davis CL, Bernard PJ, Zhu H, Gutin B, Dong Y. Greater fructose consumption is associated with cardiometabolic risk markers and visceral adiposity in adolescents. J Nutr 2012; 142: 251-257.
11. Le KA, Faeh D, Stettler R, Ith M, Kreis R, Vermathen P, Boesch C, Ravussin E, Tappy L. A 4-wk high-fructose diet alters lipid metabolism without affecting insulin sensitivity or ectopic lipids in healthy humans. Am J Clin Nutr 2006; 84: 1374-1379.
12. Schwenger KJ, Allard JP. Clinical approaches to non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20: 1712-1723.
13. Scalbert A, Manach C, Morand C, Rémésy C, Jiménez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005; 45: 287-306.
14. Ozsoy-Sacan O, Yanardag R, Orak H, Ozgey Y, Yarat A, Tunali T. Effects of parsley (Petroselinum crispum) extract versus glibornuride on the liver of streptozotocin-induced diabetic rats. J Ethnopharmacol 2006; 104: 175-181.
15. Pápay ZE, Kósa A, Boldizsár I, Ruszkai A, Balogh E, Klebovich I, Antal I. Pharmaceutical and formulation aspects of Petroselinum crispum extract. Acta Pharm Hung 2012; 82: 3-14.
16. Mahmood S, Hussain S, Malik F. Critique of medicinal conspicuousness of Parsley (Petroselinum crispum): a culinary herb of Mediterranean region. Pak J Pharm Sci 2014; 27: 193-202.
17. Baytop T. Therapy with Medicinal Plants, Past and Present. Istanbul University Publications No. 3255, Istanbul, Istanbul University Press 1984.
18. Simmon JE, Overly ME. A comparative evaluation of Petroselinium cultivars. The spice and Medicinal Plant Digest 1986; 4: 3-47.
19. Yazicioglu A, Tuzlaci E. Folk medicinal plants of Trabzon (Turkey). Fitoterapia 1996; 67 (4): 307-318.
20. Öztürk Y, Baser KHC, Aydin S. Hepatoprotective (antihepatotoxic) plants in Turkey. Proceedings of the 9th Symposium on Plant Drugs Eskisehir-Turkey 1991; 5: 40-50.
21. Jassim AM. Protective Effect of Petroselinum crispum (parsley) extract on histopathological changes in liver, kidney and pancreas induced by sodium valproate in male rats. Kufa J Vet Med Sci 2013; 4: 20-27.
22. Nielsen SE, Young JF, Daneshvar B, Lauridsen ST, Knuthsen P, Sandström B, Dragsted LO. Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr 1999; 81: 447-455.
23. Kreydiyyeh SI, Usta J, Kaouk I, Al-Sadi R. The mechanism underlying the laxative properties of parsley extract. Phytomedicine 2001; 8: 382-388.
24. Gadi D, Bnouham M, Aziz M, Ziyyat A, Legssyer A, Legrand C, Lafeve FF, Mekhfi H. Parsley extract inhibits in vitro and ex vivo platelet aggregation and prolongs bleeding time in rats. J Ethnopharmacol 2009; 125:170-174.
25. Haidari F, Keshavarz SA, Mohammad Shahi M, Mahboob SA, Rashidi MR. Effects of Parsley (Petroselinum crispum) and its Flavonol Constituents, Kaempferol and Quercetin, on Serum Uric Acid Levels, Biomarkers of Oxidative Stress and Liver Xanthine Oxidoreductase activity in Oxonate-Induced Hyperuricemic Rats. Iran J Pharm Res 2011; 10: 811-819.
26. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 497-509.
27. Mehta K, Van Thiel DH, Shah N, Mobarhan S. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002; 60: 289-293.
28. Kawano Y, Cohen DE. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 2013; 48: 434-441.
29. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-1523.
30. Te Sligte K, Bourass I, Sels JP, Driessen A, Stockbrugger RW, Koek GH. Non-alcoholic steatohepatitis: review of a growing medical problem. Eur J Intern Med 2004; 15: 10-21.
31. Panchal SK, Poudyal H, Arumugam TV, Brown L. Rutin attenuates metabolic changes, nonalcoholic steatohepatitis, and cardiovascular remodeling in high-carbohydrate, high-fat diet-fed rats. J Nutr 2011; 141: 1062-1069.
32. Kawasaki T, Igarashi K, Koeda T, Sugimoto K, Nakagawa K, Hayashi S, Yamaji R, Inui H, Fukusato T, Yamanouchi T. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 2009; 139: 2067-2071.
33. Parekh S, Anania FA. Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease. Gastroenterology 2007; 132: 2191-2207.
34. Pantsari MW, Harrison SA. Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase. J Clin Gastroenterol 2006; 40: 633-635.
35. Verrijken A, Francque S, Mertens I, Talloen M, Peiffer F, Van Gaal L. Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients. Int J Obes (Lond) 2010; 34: 899-907.
36. Loria P, Lonardo A, Carulli L, Verrone AM, Ricchi M, Lombardini S, Rudilosso A, Ballestri S, Carulli N. Review article: the metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2005; 22: 31-36.
37. Yan E, Durazo F, Tong M, Hong K. Nonalcoholic fatty liver disease: pathogenesis, identification, progression, and management. Nutr Rev 2007; 65: 376-384.
38. Adams LA, Feldstein AE. Non-invasive diagnosis of nonalcoholic fatty liver and nonalcoholic steatohepatitis. J Dig Dis 2011; 12: 10-16.
39. Pratt DS, Kaplan MM. Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med 2000; 342: 1266-1271.
40. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905.
41. Festi D, Schiumerini R, Marzi L, Di Biase AR, Mandolesi D, Montrone L, Scaioli E, Bonato G, Marchesini-Reggiani G, Colecchia A. Review article: the diagnosis of non-alcoholic fatty liver disease availability and accuracy of non-invasive methods. Aliment Pharmacol Ther 2013; 37: 392-400.
42. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94: 1018-1022.
43. El-Kherbawy GM, Ibrahem ES, Zaki SA. Effects of Parsley and Coriander leaves on hypercholesterolemic rats. The 6th Arab and 3rd International Annual Scientific Conference 2011; 1227-1240.